Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist.
What To Do In Aachen This Weekend? Sitting on Sundays or being a couch potato on Saturdays is definitely a boring plan. Move out and make memories. Discover the best things to do this weekend in ...